Gene: ZBTB3
Official Full Name: zinc finger and BTB domain containing 3provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12498 | ZBTB3 Knockout cell line (HeLa) | Human | ZBTB3 | 1:3~1:6 | Negative | Online Inquiry |
KO12499 | ZBTB3 Knockout cell line (HCT 116) | Human | ZBTB3 | 1:2~1:4 | Negative | Online Inquiry |
KO12500 | ZBTB3 Knockout cell line (HEK293) | Human | ZBTB3 | 1:3~1:6 | Negative | Online Inquiry |
KO12501 | ZBTB3 Knockout cell line (A549) | Human | ZBTB3 | 1:3~1:4 | Negative | Online Inquiry |
ZBTB3 Gene Knockout Cell Lines are genetically modified cellular systems specifically designed to study the functions of the ZBTB3 gene, pivotal in the regulation of various cellular processes. These cell lines have been engineered through advanced CRISPR/Cas9 technology, enabling precise deletion of the ZBTB3 gene, thereby allowing researchers to investigate its role in gene expression, cell differentiation, immune responses, and various pathways related to cell growth and apoptosis.
The primary function of these knockout cell lines is to elucidate the mechanistic insights into the biological processes that ZBTB3 influences. By observing the phenotypic changes and molecular alterations that occur post-knockout, scientists can uncover critical interactions that ZBTB3 engages in, which may have implications in cancer research, developmental biology, or immunology. The manipulation of the ZBTB3 gene lends itself to a myriad of applications, from basic research exploring gene functions to translational studies that seek to develop therapeutic strategies for diseases associated with ZBTB3 dysregulation.
A distinct advantage of our ZBTB3 Gene Knockout Cell Lines lies in their reliability and reproducibility, setting them apart from traditional approaches that may employ less precise gene silencing techniques. The specificity of CRISPR/Cas9 ensures complete and targeted knockout, reducing off-target effects commonly associated with other genetic modification methods. Additionally, our cell lines are backed by comprehensive characterization, providing users with data on gene expression levels, cellular responses, and overall integrity, facilitating seamless integration into existing research protocols.
For researchers and clinicians, these knockout cell lines represent a valuable tool that can accelerate discoveries in gene function and regulation, especially in complex biological systems. Our product empowers users to push the boundaries of current knowledge and explore novel therapeutic paths, ultimately enhancing the understanding of critical biological mechanisms.
At [Company Name], we pride ourselves on our commitment to excellence in biotechnology, offering a range of genetically modified cell lines supported by rigorous scientific validation. With years of expertise and a focus on innovation, we equip researchers and clinicians with the cutting-edge tools they need to advance their work and achieve breakthroughs in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.